Market Research Logo

NanoString Technologies Inc (NSTG) - Product Pipeline Analysis, 2018 Update

Summary

NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company's products include sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways, among others. Its nCounter MAX analysis system provides cost-effective method to profile various miRNA, miRGE or DNA molecules simultaneously employing a novel digital molecular barcoding technology. The company sells its products through direct sales force and distributors in Austria, Poland, Czech Republic, Slovakia, Hungary, Croatia, Slovenia, Bosnia Herzegovina, Serbia, Romania, Albania, Macedonia and Bulgaria, among others. NanoString is headquartered in Seattle, Washington, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company NanoString Technologies Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


NanoString Technologies Inc Company Overview
NanoString Technologies Inc Company Snapshot
NanoString Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
NanoString Technologies Inc – Pipeline Analysis Overview
NanoString Technologies Inc - Key Facts
NanoString Technologies Inc - Major Products and Services
NanoString Technologies Inc Pipeline Products by Development Stage
NanoString Technologies Inc Pipeline Products Overview
Advanced Gene Expression Assay
Advanced Gene Expression Assay Product Overview
Companion Diagnostic Test - Enzalutamide
Companion Diagnostic Test - Enzalutamide Product Overview
Digital Immunohistochemistry Device
Digital Immunohistochemistry Device Product Overview
Immune-Related Gene Expression Assay
Immune-Related Gene Expression Assay Product Overview
In Vitro Diagnostic Assay - HCC Gene Signature
In Vitro Diagnostic Assay - HCC Gene Signature Product Overview
Multi-Omic Assay
Multi-Omic Assay Product Overview
nCounter Dx LymphMark Assay
nCounter Dx LymphMark Assay Product Overview
NanoString Technologies Inc - Key Competitors
NanoString Technologies Inc - Key Employees
NanoString Technologies Inc - Locations And Subsidiaries
Head Office
Recent Developments
NanoString Technologies Inc, Recent Developments
Jun 18, 2018: NanoString Establishes Netherlands Cancer Institute as a Center of Excellence for Digital Spatial Profiling
May 31, 2018: NanoString Highlights Record Number of nCounter-Based Abstracts at the 2018 Annual Meeting of the American Society of Clinical Oncology
May 08, 2018: NanoString Technologies Releases Operating Results for First Quarter of 2018
Feb 15, 2018: First comparison of common breast cancer tests finds varied accuracy of predictions
Feb 14, 2018: FDA Clears Glooko’s Long-Acting Insulin Titration System
Feb 05, 2018: NanoString Announces Largest and Most Comprehensive Study to Date of Prosigna Breast Cancer Assay Published in Journal of Clinical Oncology
Jan 16, 2018: NanoString Appoints Thomas Bailey as Chief Financial Officer
Jan 08, 2018: NanoString Technologies Provides Preliminary Operational and Financial Results for Fourth Quarter and Fiscal Year 2017
Dec 07, 2017: NanoString Technologies Highlights Advances in Precision Oncology at the 59th Annual Meeting of the American Society of Hematology
Nov 09, 2017: NanoString Highlights Record Number of nCounter-Based Research Abstracts at the 2017 Annual Meeting of the Society of Immunotherapy of Cancer (SITC)
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
NanoString Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
NanoString Technologies Inc Pipeline Products by Equipment Type
NanoString Technologies Inc Pipeline Products by Indication
NanoString Technologies Inc, Key Facts
NanoString Technologies Inc, Major Products and Services
NanoString Technologies Inc Number of Pipeline Products by Development Stage
NanoString Technologies Inc Pipeline Products Summary by Development Stage
Advanced Gene Expression Assay - Product Status
Advanced Gene Expression Assay - Product Description
Companion Diagnostic Test - Enzalutamide - Product Status
Companion Diagnostic Test - Enzalutamide - Product Description
Digital Immunohistochemistry Device - Product Status
Digital Immunohistochemistry Device - Product Description
Immune-Related Gene Expression Assay - Product Status
Immune-Related Gene Expression Assay - Product Description
In Vitro Diagnostic Assay - HCC Gene Signature - Product Status
In Vitro Diagnostic Assay - HCC Gene Signature - Product Description
Multi-Omic Assay - Product Status
Multi-Omic Assay - Product Description
nCounter Dx LymphMark Assay - Product Status
nCounter Dx LymphMark Assay - Product Description
NanoString Technologies Inc, Key Employees
Glossary
List of Figures
NanoString Technologies Inc Pipeline Products by Equipment Type
NanoString Technologies Inc Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report